BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai E, Zhu Z, Wahed S, Qu Z, Storkus WJ, Guo ZS. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Mol Cancer 2021;20. [DOI: 10.1186/s12943-021-01464-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Ming T, Tao Q, Tang S, Zhao H, Yang H, Liu M, Ren S, Xu H. Curcumin: An epigenetic regulator and its application in cancer. Biomedicine & Pharmacotherapy 2022;156:113956. [DOI: 10.1016/j.biopha.2022.113956] [Reference Citation Analysis]
2 Zhang S, Meng Y, Zhou L, Qiu L, Wang H, Su D, Zhang B, Chan K, Han J. Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy. MedComm 2022;3. [DOI: 10.1002/mco2.173] [Reference Citation Analysis]
3 Anichini A, Molla A, Nicolini G, Perotti VE, Sgambelluri F, Covre A, Fazio C, Lofiego MF, Di Giacomo AM, Coral S, Manca A, Sini MC, Pisano M, Noviello T, Caruso F, Brich S, Pruneri G, Maurichi A, Santinami M, Ceccarelli M, Palmieri G, Maio M, Mortarini R, On behalf of the EPigenetic Immune-oncology Consortium AIRC (EPICA) investigators. Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy. J Exp Clin Cancer Res 2022;41:325. [DOI: 10.1186/s13046-022-02529-5] [Reference Citation Analysis]
4 ElBakary NM, Hagag SA, Ismail MA, El-Sayed WM. New thiophene derivative augments the antitumor activity of γ-irradiation against colorectal cancer in mice via anti-inflammatory and pro-apoptotic pathways. Discov Oncol 2022;13:119. [PMID: 36326938 DOI: 10.1007/s12672-022-00583-1] [Reference Citation Analysis]
5 Zwergel C, Fioravanti R, Mai A. PD-L1 small-molecule modulators: a new hope in epigenetic-based multidrug cancer therapy? Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.103435] [Reference Citation Analysis]
6 Cai R, Wang M, Liu M, Zhu X, Feng L, Yu Z, Yang X, Zhang Z, Guo H, Guo R, Zheng Y. An iRGD ‐conjugated photothermal therapy‐responsive gold nanoparticle system carrying siCDK7 induces necroptosis and immunotherapeutic responses in lung adenocarcinoma. Bioengineering & Transla Med 2022. [DOI: 10.1002/btm2.10430] [Reference Citation Analysis]
7 Ma X, Zhu H, Cheng L, Chen X, Shu K, Zhang S. Targeting FGL2 in glioma immunosuppression and malignant progression. Front Oncol 2022;12:1004700. [DOI: 10.3389/fonc.2022.1004700] [Reference Citation Analysis]
8 Giampietri C, Scatozza F, Crecca E, Vigiano Benedetti V, Natali PG, Facchiano A. Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies. J Transl Med 2022;20:467. [PMID: 36224560 DOI: 10.1186/s12967-022-03670-7] [Reference Citation Analysis]
9 Zhu Z, McGray AJR, Jiang W, Lu B, Kalinski P, Guo ZS. Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways. Mol Cancer 2022;21:196. [PMID: 36221123 DOI: 10.1186/s12943-022-01664-z] [Reference Citation Analysis]
10 Quan Y, Zhang X, Wang M, Ping H. Histone lysine methylation patterns in prostate cancer microenvironment infiltration: Integrated bioinformatic analysis and histological validation. Front Oncol 2022;12:981226. [DOI: 10.3389/fonc.2022.981226] [Reference Citation Analysis]
11 Wen Z, Zhang Y, Feng J, Aimulajiang K, Aleem MT, Lu M, Xu L, Song X, Li X, Yan R. Excretory/secretory proteins inhibit host immune responses by downregulating the TLR4/NF-κB/MAPKs signaling pathway: A possible mechanism of immune evasion in parasitic nematode Haemonchus contortus. Front Immunol 2022;13:1013159. [DOI: 10.3389/fimmu.2022.1013159] [Reference Citation Analysis]
12 Sun Y, Hong JH, Ning Z, Pan D, Fu X, Lu X, Tan J. Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment. Front Pharmacol 2022;13:932914. [DOI: 10.3389/fphar.2022.932914] [Reference Citation Analysis]
13 Anichini A, Molla A, Nicolini G, Perotti VE, Sgambelluri F, Covre A, Fazio C, Lofiego MF, Giacomo AMD, Coral S, Manca A, Sini MC, Pisano M, Noviello T, Caruso F, Brich S, Pruneri G, Maurichi A, Santinami M, Ceccarelli M, Palmieri G, Maio M, Mortarini R. Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.. [DOI: 10.21203/rs.3.rs-1918233/v1] [Reference Citation Analysis]
14 Yang M, Olaoba OT, Zhang C, Kimchi ET, Staveley-o’carroll KF, Li G. Cancer Immunotherapy and Delivery System: An Update. Pharmaceutics 2022;14:1630. [DOI: 10.3390/pharmaceutics14081630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wang M, Yu F. Research Progress on the Anticancer Activities and Mechanisms of Polysaccharides From Ganoderma. Front Pharmacol 2022;13:891171. [DOI: 10.3389/fphar.2022.891171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang G, Gao Y, Chen Y, Wang K, Zhang S, Li G. Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development. Front Oncol 2022;12:921711. [DOI: 10.3389/fonc.2022.921711] [Reference Citation Analysis]
17 Park M, Kim D, Ko S, Kim A, Mo K, Yoon H. Breast Cancer Metastasis: Mechanisms and Therapeutic Implications. Int J Mol Sci 2022;23:6806. [PMID: 35743249 DOI: 10.3390/ijms23126806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chen Y, Yi X, Sun N, Guo W, Li C. Epigenetics Regulates Antitumor Immunity in Melanoma. Front Immunol 2022;13:868786. [PMID: 35693795 DOI: 10.3389/fimmu.2022.868786] [Reference Citation Analysis]
19 Guo ZS, Kalinski P, Chen H, Zhu Z. Immunogenic cell death‐inducing small molecule inhibitors: Potential for immunotherapy of cancer. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.69] [Reference Citation Analysis]
20 Aviña-padilla K, Ramírez-rafael JA, Herrera-oropeza GE, Romero G, Zambada-moreno O, Gupta I, Hernández-rosales M. Deciphering the tissue-specific regulatory role of intronless genes across cancers.. [DOI: 10.1101/2022.02.21.481319] [Reference Citation Analysis]
21 Aviña-padilla K, Ramírez-rafael JA, Zambada-moreno O, Herrera-oropeza GE, Romero G, Gupta I, Hernández-rosales M. Deciphering the Tissue-Specific Regulatory Role of Intronless Genes Across Cancers. Comparative Genomics 2022. [DOI: 10.1007/978-3-031-06220-9_18] [Reference Citation Analysis]